Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutchs pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nations first cancer prevention research program, as well as the clinical coordinating center of the Womens Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
About the Womens Health Initiative
The National Institutes of Health (NIH) established the Women's Health Initiative (WHI) in 1991 to address the most common causes of death, disability and impaired quality of life in postmenopausal women. The WHI is one of the largest U.S. prevention studies of its kind and it is currently moving into its third extension. The WHI Clinical Coordinating Center (CCC), located at Fred Hutch, is responsible for study implementation and coordination of statistical, epidemiologic, nutritional and clinical aspects of the WHI and is responsible for data collection, management and analysis. Data and biospecimens are available to researchers with approved ancillary studies with outside funding. The WHI CCC serves as a subcontractor to the ancillary studies to coordinate the CCC-related operations, including but not limited to study team management, biospecimen processing and shipping, consenting when needed and return of results to the CCC.
The WHI CCC seeks a Research Project Manager II to conduct CCC operational components of WHI ancillary studies (AS). This starts with research proposal review and continues throughout the active award and data return phases.
The proposal review addresses epidemiological design features and biospecimen usage (appropriate specimen type, volume and number, and lab assay and related aspects). For participant-involved ancillary studies, review assesses whether WHI participants need to be introduced to the AS through an informational packet followed by consent transfer, i.e., consenting to be contacted by the AS team.
Once a study is activated, this person will lead a multidisciplinary team to finalize the CCC implementation of the study, launch and coordinate CCC operations, respond to questions, track receipt of AS data, and apply and report on QA data and resolve issues that may arise. This person will organize biospecimen shipping and processing that precedes shipping to AS laboratories, responds to questions, and for participant studies, assists with consent transfer if needed. The person in this position will work closely with CCC administration to develop a CCC budget to support the CCC operational efforts.
Data return involves oversight of biospecimen data that are returned to the CCC. Data files may vary in size from single assay results to large data files such as those from genome, proteome or metabolome (omic) assays. For participant-involved AS, data return may include questionnaire or device data.
This person will serve as a biospecimen knowledge resource for the CCC and for the larger WHI program. The person in this position must be facile with interactions among a wide range of individuals with diverse training including laboratory scientists and technicians, epidemiologists, statisticians, administrators, and staff from data operations, database and outcomes. Familiarity with routine laboratory quality assurance (QA) approaches is critical as is the ability to analyze and interpret the resultant QA data. This person will work closely with CCC staff in the Publications/Presentations and Ancillary Studies Committees Support (PASC) Unit and report to the PASC unit manager.
Review incoming ancillary studies for aspects that involve biospecimens or participants
Conduct WHI ancillary study CCC operations that involve biospecimen resources and those that involve participants when consent transfer is needed
Manage return of ancillary study data from biospecimen analyses, questionnaire and device data and large file omics data
Analyze and report on quality assurance data from ancillary studies and help resolve issues that may arise
Maintain organization of ancillary study documentation
Provide guidance to CCC staff regarding biospecimens and laboratory assays
Serve as a resource for biospecimen questions
Collaborate with multidisciplinary teams to support ancillary studies
Serve as liaison to operational staff at WHIs offsite biorepository and the Fred Hutch specimen processing labs
Organize quarterly calls with the Lab Working Group calls to discuss AS data quality
Lead twice monthly ancillary study review meetings with the CCC ancillary study team
Participate in the monthly Publications/Presentations and Ancillary Studies Committees Support (PASC) Unit meetings and other meetings as needed
Perform other duties as described in the position summary or as assigned
3 years of research project management experience or transferable project management experience in a related field
Lab background or experience working with research labs
Experience with laboratory quality assurance programs
Organizational skills including critical thinking, ability to work independently and with a team, being proactive, self-motivated and being a good listener
Written and oral communication skills with varied audiences (review committees, study PI, administration, statisticians, database, processing labs, and testing labs)
Computer skills with high proficiency in a variety of software packages, including MS Word, MS Excel, MS Outlook
Data handling skills
BA or BS in a biological science or related field
Preferred qualifications in addition to minimum qualifications
MPH or MS
research study designs
research grant proposals
basic research components including biomarkers, genetics, proteomics, metabolomics, methylation and epigenetics
participant related data such as questionnaires or devices
cardiovascular diseases and cancer
Experience working with remote study-related staff and investigators, relying primarily on phone, email, or internet communication for part of duties
Our Commitment to Diversity
We are proud to be an Equal Employment Opportunity (EEO) and Vietnam Era Veterans Readjustment Assistance Act (VEVRAA) Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability (physical or mental), marital or veteran status, genetic information, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to our Employee Services Center at hrop[email protected] or by calling 206-667-4700.
At Fred Hutchinson Cancer Research Center, teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Researchers are discovering new ways to detect cancers earlier, improve treatments, and learn how to prevent cancers from growing. Although Fred Hutchinson opened its doors in 1975, its history began about 20 years before that. In 1962 Fred Hutchinson envisioned a center devoted to studying cancer, a disease that took his brother’s life. Today Fred Hutchinson is contributing to the next waves of breakthrough treatments and prevention strategies. Fred Hutchinson collaborates with the Seattle Cancer Alliance, the National Cancer Institute, and the University of Washington.